Carlsmed Raises $2.5M to Improve Complex Spine Surgery

June 23, 2020

Carlsmed announced the close of an oversubscribed $2.5M seed round. The round was led by Cove Fund II, a prominent California Life Science and Technology fund.

Carlsmed notes participating in the round are MedTech funds Wavemaker Three-Sixty Health and Device of Tomorrow Capital, as well as individual MedTech investors.

We are very bullish about the prospects for Carlsmed,” said Mike Benvenuti, Co-Manager of Cove Fund II. “Carlsmed’s team has the deep industry experience and operational expertise to lead the much-needed shift to personalized medicine for challenging complex spine cases and beyond.”

“This round of venture financing accelerates the clinical launch of the aprevo™ system,” said Mike Cordonnier, CEO, and co-founder of Carlsmed. “Surgeons and patients across the spectrum that have postponed treatment for debilitating spinal conditions will soon have access to an affordable and streamlined system for personalized spine surgery.”

Today, Carlsmed also announced the appointment of Alexander Arrow, MD, CFA, as Chief Financial Officer and Shariq Hussain as Chief Information Officer, leading the company’s digital development and operations. These two additions to the team are instrumental in building the infrastructure and systems to scale the company to meet the clinical demand.

Dr. Arrow is a MedTech executive with 20+ years of C-suite and financial leadership roles including CFO of Protagenic Therapeutics, Inc. (PTIX), CEO of Zelegent, Inc., and President, COO, and Director of Biolase, Inc. (BIOL). Dr. Arrow also served as Chief Medical Officer of Stanford-affiliated neuroscience company Circuit Therapeutics, Inc., and as CFO of cardiovascular device manufacturer Arstasis, Inc. He also spent two years as CFO of the Patent & License Exchange, Inc. Prior to joining the MedTech industry, he spent nine years in equity research on Wall Street, most recently as head of MedTech research at Lazard, Ltd. He has an M.D. from Harvard Medical School and a B.A. in Biophysics from Cornell University.

Mr. Hussain is a serial entrepreneur in the MedTech industry. As co-founder, and past CEO and CTO, of IntelliGuard, he developed fully integrated hospital inventory management solutions of high-value pharmaceuticals. Previously, he led Systems Integration and Cybersecurity for startup Safety Syringes, which resulted in its successful acquisition by Becton Dickinson. He has a B.S. in Computer Science and Engineering from the University of California San Diego and an M.B.A. from National University.

Hot this week

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution